DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Article Abstract:
Immunohistochemical analysis is used to determine the expression of the excision repair cross-complementation group 1 (ERCC1) protein in operative specimens of non-small-cell lung cancer through comparison of the effect of adjuvant cisplatin-based chemotherapy on survival. Patients with completely resected non-small-cell lung cancer and ERCC1-negative tumors appear to benefit from adjuvant cisplatin-based chemotherapy, whereas patients with ERCC1-positive tumors do not.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Tyrosine Kinases as targets for cancer therapy
Article Abstract:
Protein Tyrosine Kinases (TKs) are enzymes that catalyze the transfer of phosphate from ATP to tyrosine residues in polypeptides. The mechanisms of aberrant TK signaling and strategies to inhibit TKs in cancer are reviewed, the status of TK-directed cancer therapies is summarized, and the challenges and prospects for the future are discussed.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Curing Cancer with p53
Article Abstract:
The activity of p53 tumor suppressor protein plays an important role in controlling cancer. Such a progress will further encourage the investment needed to support clinical trials.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Regionalization of high-risk surgery and implications for patient travel times. Disparities in the utilization of high-volume hospitals for complex surgery
- Abstracts: Clues to gene activity in inflammation found. Progress in antisense technology
- Abstracts: Two steps forward in the treatment of Colorectal Cancer.. Surveillance strategies after curative treatment of Colorectal Cancer
- Abstracts: A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer